OIP5 and hepatocellular carcinoma: Next, we determined whether OIP5 is involved in the activation of mTORC2, p38, PTEN, PI3K, PDK1, or ERK1/2 (Figure 4C), as activation of the PI3K/AKT and MAPK pathways is commonly implicated in HCC [14, 15].